agilon health - AGL EV/Sales Multiple

Public company logo of agilonhealth.com (AGL)

Rising costs in Medicare Advantage have triggered volatility, and this GURU.Markets terminal chart illustrates the EV/Sales multiple trend, where the 206.89 mark indicates the business valuation level. Agilon Health (AGL) monetizes the optimization of government spending through specialized software for geriatricians, recruiting data analysts via remote formats and stock options to improve the quality of primary healthcare.

agilon health, inc. (AGL) - Company Value to Revenue from 11/23/2025 to 11/19/2026

agilon health, inc. - analytical breakdowns and key metrics (AGL)

Fundamental company valuation:AGL agilonhealth.com
Product sample of agilon health

Complex data integration and stringent information security standards create high switching costs for Agilon Health (AGL) customers. The EV/Sales ratio compares the total enterprise value to annual revenue, eliminating the impact of debt load on the valuation. By analyzing the price-to-sales multiple dynamics on GURU.Markets, an investor can determine the real price per unit of sales. A decline in this metric may signal that the asset is undervalued. This indicator determines the fundamental attractiveness of the shares within the healthcare sector.

Competitor analysis

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)